Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions.
Cuisset
Thomas
T
Department of Cardiology, University Hospital La Timone, Marseille, France. thomascuisset@voila.fr
Mudra
Harald
H
Muller
Oliver
O
Vogt
Pierre
P
Angelillo-Scherrer
Anne
A
Huber
Kurt
K
D015906:Angioplasty, Balloon, Coronary; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors